5\. Compliance: Ability and willingness to comply with all study procedures, follow-up visits, and study medication requirements.
6.Informed Consent: Participants must provide written informed consent before any study-specific procedures are performed.
7 Female participants must be non-pregnant and non-lactating, or, if of childbearing potential, must agree to use effective contraception during the study
You may not be if
1\. Patients with known hypersensitivity to taurine or any of its components
2\. Women who are pregnant or breastfeeding
3\. Patients currently participating in other clinical trials
4\. Patients who refuse to participate in the relevant clinical study
Clareo Health | A Multicenter Clinical Trial Evaluating the Efficacy and Safety of Taurine as an Adjunctive Therapy in Multiple Sclerosis
